Why did CurveBeam AI (ASX:CVB) raise this capital?

CurveBeam AI (ASX:CVB) raised these funds to finance its sales, marketing, research and development, supply chain operations, and general working capital. The company stated that the capital will specifically support its upcoming product launch in the Chinese market.

What are the financial details of the CurveBeam AI (ASX:CVB) capital placement?

CurveBeam AI (ASX:CVB) secured $5 million through an institutional and related party share placement priced at $0.02 per new share. This offer price represents an 11.1% premium to the company's closing share price of A$0.018 recorded on July 3.

How is the upcoming CurveBeam AI (ASX:CVB) share purchase plan structured?

CurveBeam AI (ASX:CVB) proposed a separate Share Purchase Plan to raise up to an additional $1 million. Eligible shareholders in Australia and New Zealand will be able to buy these new shares at a price of $0.018 per share.

What does the insider participation mean for CurveBeam AI (ASX:CVB)?

Company directors Greg Brown and Arun Singh heavily backed CurveBeam AI (ASX:CVB) by contributing a combined $2.4 million directly to the $5 million placement.

What geographic market impact does CurveBeam AI (ASX:CVB) expect from this funding?

CurveBeam AI (ASX:CVB) expects this capital to directly accelerate its international expansion, with a particular strategic focus on launching its clinical software and medical imaging equipment in China.

Technology

Image for illustrative purposes only. Not a real photo.

CurveBeam AI secures $5M capital placement

Written by Liezl GambePublished Jul 8, 2026, 6:52 AM

CurveBeam AI secured a $1 million share purchase plan.
The placement shares are priced at $0.02, representing an 11.1% premium to the recent closing price.
The company stated that the capital will fund working capital and its China market launch.

CurveBeam AI (ASX:CVB) has secured a $1 million share purchase plan.

The placement price of $0.02 represents an 11.1% premium to the July 3 closing price.

Company directors Greg Brown and Arun Singh contributed a combined $2.4 million to the capital raising.

Director Arun Singh also advanced $2.1 million to the company to maintain normal trading operations.

Following the announcement, the CurveBeam AI share price was up at $0.019.

The business stated that net proceeds will fund sales, research, and its China market launch.

The company develops point-of-care specialised medical imaging equipment and AI-enabled clinical software.

CurveBeam AI secures $5M capital placement

Frequently asked questions

Assets related to this article